Evidence map›Paper›PMID 23297181›Full record

ReviewAmerican journal of perinatology2013

Role of innate immunity in neonatal infection.

Alex G Cuenca, James L Wynn, Lyle L Moldawer, Ofer Levy

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in American journal of perinatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02554630 (Novel Mechanisms and Approaches to Treat Neonatal Sepsis), which is not on this map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02554630 completednot on this mapstarted 2016, after this paper: background citation

Novel Mechanisms and Approaches to Treat Neonatal Sepsis: Adjuvant Therapies, Host Microbiome, and Genomic Expression and Functional Capacity of Innate Immune Cells

TypeobservationalSponsorUniversity of FloridaRan2016 to 2022Enrolled142ConditionsComplication of Prematurity, Immunologic Deficiency SyndromesArmsAdjuvant, Blood Collection
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 161 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Duration of Antibiotic Therapy forThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  5. Review
  6. Article
  7. Development of a mouse model forMicrobiology spectrum · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Epidermal Immunity and Function: Origin in Neonatal Skin.Frontiers in molecular biosciences · 2022
    Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alex G CuencaDepartment of Surgery, University of Florida, Gainesville, FL, USA.
James L Wynn
Lyle L Moldawer
Ofer Levy
University of Florida · USHarvard University · USVanderbilt University · US

Funding

Molecular Biology in Burns and TraumaT32GM008721 · NIGMS · UNIVERSITY OF FLORIDA · PI Philip A Efron · 1999 to 2026
$5.0M
REGULATION ON MONOKINE PRODUCTION IN TRAUMA AND SURGERYR01GM040586 · NIGMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MOLDAWER, LYLE L · 1988 to 2016
$2.6M
Modeling distinct neonatal purine metabolism to inform vaccine developmentR01AI100135 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2012 to 2016
$2.5M
Novel Mechanisms and Approaches to Treat Neonatal SepsisR01GM097531 · NIGMS · UNIVERSITY OF FLORIDA · PI LARSON, SHAWN DAVID, MOLDAWER, LYLE L · 2011 to 2018
$2.3M
CYTOKINE REGULATION IN SEPSIS/INFLAMMATIONR37GM040586 · NIGMS · UNIVERSITY OF FLORIDA · PI MOLDAWER, LYLE L · 1998 to 2007
$2.3M
Myeloid Suppressor Cells in Sepsis and TraumaR01GM081923 · NIGMS · UNIVERSITY OF FLORIDA · PI MOLDAWER, LYLE L · 2008 to 2014
$1.8M
TLR4 signaling in the innate immune response to neonatal sepsisF32GM093665 · NIGMS · UNIVERSITY OF FLORIDA · PI CUENCA, ALEX · 2010 to 2010
$52k
NIAID NIH HHS 1R01AI100135-01NIAID NIH HHS R01 AI100135NIGMS NIH HHS F32 GM-093665NIGMS NIH HHS F32 GM093665NIGMS NIH HHS GM-40586NIGMS NIH HHS GM-81923NIGMS NIH HHS R01 GM040586NIGMS NIH HHS R01 GM081923NIGMS NIH HHS R01 GM097531NIGMS NIH HHS R37 GM040586NIGMS NIH HHS T32 GM008721NIGMS NIH HHS T32 GM-08721
6 · The paper itself

Abstract

Newborns are at increased risk of infection due to genetic, epigenetic, and environmental factors. Herein we examine the roles of the neonatal innate immune system in host defense against bacterial and viral infections. Full-term newborns express a distinct innate immune system biased toward T(H)2-/T(H)17-polarizing and anti-inflammatory cytokine production with relative impairment in T(H)1-polarizing cytokine production that leaves them particularly vulnerable to infection with intracellular pathogens. In addition to these distinct features, preterm newborns also have fragile skin, impaired T(H)17-polarizing cytokine production, and deficient expression of complement and of antimicrobial proteins and peptides (APPs) that likely contribute to susceptibility to pyogenic bacteria. Ongoing research is identifying APPs, including bacterial/permeability-increasing protein and lactoferrin, as well as pattern recognition receptor agonists that may serve to enhance protective newborn and infant immune responses as stand-alone immune response modifiers or vaccine adjuvants.

Indexed as

Immunity, InnateAntimicrobial Cationic PeptidesBacterial InfectionsBlood ProteinsCytokinesHumansInfant, NewbornInflammasomesLactoferrinLectins, C-TypeReceptors, Cytoplasmic and NuclearSepsisSignal TransductionToll-Like ReceptorsVirus DiseasesAntimicrobial Cationic Peptidesbactericidal permeability increasing proteinBlood ProteinsCytokinesInflammasomesLactoferrinLectins, C-TypeReceptors, Cytoplasmic and NuclearToll-Like Receptors

Identifiers

PMID23297181
PMCPMC3959733
OpenAlexW2058645677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.